Your new experience awaits. Try the new design now and help us make it even better

SYSTEMATIC REVIEW article

Front. Psychiatry

Sec. Digital Mental Health

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1643496

This article is part of the Research TopicExpanding the Reach of Evidence-Based Psychological Interventions for Mental Health: Innovation, Access, and EquityView all 6 articles

Treatment discontinuation of remotely delivered cognitive remediation for schizophrenia: a systematic review and meta-analysis

Provisionally accepted
Min  WenMin Wen1Jie  ZhangJie Zhang1Keqing  JiangKeqing Jiang1Juan  LiuJuan Liu2*Xiaodan  ZhuXiaodan Zhu1*
  • 1School of nursing, Ningxia Medical University, Yinchuan, China
  • 2General Hospital of Ningxia Medical University, Yinchuan, China

The final, formatted version of the article will be published soon.

Introduction Cognitive remediation therapy (CRT) is a pivotal treatment for cognitive impairments in patients with schizophrenia. However, there is a large proportion of community-dwelling patients with schizophrenia, and access to this therapy is not fully equalized across regions. The introduction of remotely delivered CRT presents a promising solution to these limitations. Given the substantial variation in settings for remotely delivered CRT, its treatment discontinuation and the factors influencing it remain to be fully elucidated. This meta-analysis aims to examine the treatment discontinuation of remotely delivered CRT and the factors influencing its treatment discontinuation. Methods This study systematically searched PubMed, Embase, EBSCO, WHO ICTRP, ClinicalTrials, ProQuest, and BASE databases to identify randomized controlled trials involving remotely delivered CRT. Meta-analyses were performed using both random-effects and fixed-effects models. Subgroup and meta-regression analyses were employed to investigate potential factors affecting the treatment discontinuation of remotely delivered CRT. Result The literature search yielded 2173 studies. 20 studies met the inclusion criteria and reported on 20 randomized controlled trials comparing remotely delivered CRT with control groups. Dropout rates were 22.96% for the remotely delivered CRT group and 20.82% for the control group. Meta-analysis results indicated no significant difference in dropout rate between the two groups (OR 0.99 [95% CI 0.78-1.25], p = 0.901). Subgroup and meta-regression analyses identified that the development of cognitive strategies, facilitating the transfer of cognitive gains to everyday functioning, and the inclusion of all core CRT core components were associated with lower rates of treatment discontinuation in remotely delivered CRT. Conclusion Remotely delivered CRT demonstrates efficacy comparable to other forms of cognitive remediation, yet it exhibits a higher rate of treatment discontinuation. Future studies should consider the specificities of the target population and their environmental context, designing more meticulous and rigorous protocols to optimize the efficacy and treatment continuation of remotely delivered CRT.

Keywords: Schizophrenia, Remote, Treatment discontinuation, cognitive remediation, randomized controlled trial

Received: 09 Jun 2025; Accepted: 30 Sep 2025.

Copyright: © 2025 Wen, Zhang, Jiang, Liu and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Juan Liu, ryuken0518@163.com
Xiaodan Zhu, zhuxiaodan007@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.